Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...

We review the current state of influenza, from its virology and public health impact to the limitations of vaccination and ...

A recent forum by Taiwan's National Development Council presented a roadmap for applied AI. The strategy shifts focus from ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

Artificial intelligence is redefining how societies perceive and respond to environmental health threats, particularly in regions where air quality and ...

On October 27, 2025, an MIT (Massachusetts Institute of Technology) lab held a closed-door demonstration event, releasing its latest research achievement: the "FiberCircuits" intelligent fiber ...

Background Hospital incident reporting and patient concerns systems are widely used to detect and respond to patient harm.

At Rutgers NJMS, art and music are helping future doctors strengthen empathy, sharpen observation skills and bring humanity ...

MoneyWeek's experts tell us what they would go for if they could pick only one stock, sector or market for the next quarter-century. Tips range from defence and agriculture to Vietnam and Jardine Math ...

We are a society in desperate need of healing; these days, we cannot even find agreement in diagnosis. Consider the issue of vaccination, which raises the specter of science in conflict with ...

Experts define droplets as larger and heavier, and they are best spread when people are within six feet of each other before ...

NNVC READ THE FULL NNVC RESEARCH REPORT Business Update Mpox Trial to Initiate in Late 2025/Early 2026 NanoViricides, Inc. (NYSE:NNVC) is planning to initiate a Phase 2 clinical trial for the ...